Proshares Trust ZBIO
ZBIO
$28.18 +1.47 (+5.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Revenue (2023 - 2026)

Updated

Zenas BioPharma's Revenue came in at $1 million for Q2 2026.

Analysis

Zenas BioPharma (ZBIO) Revenue (2023 - 2026) Analysis & Trends

For FY2025, Zenas BioPharma's Revenue was $10 million, up 100.0% from FY2024.

  • Going back by year, Revenue was $5 million in FY2024 (-90.0%) and $50 million in FY2023.
  • The Q2 2026 figure represents the highest quarterly Revenue since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Zenas BioPharma 1.77 Bn 1.10 Bn - 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2025 10.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2023 50.00 Mn
API Access

Zenas BioPharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ZBIO&period=max&api_key=YOUR_API_KEY